Selexipag use is not recommended in patients taking a strong CYP2C8 inhibitor

Diane S. Aschenbrenner

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{305c1a13d3fc4ceca32dcc02079ba054,

title = "Selexipag use is not recommended in patients taking a strong CYP2C8 inhibitor",

author = "Aschenbrenner, {Diane S.}",

year = "2016",

doi = "10.1097/01.NAJ.0000482134.59059.30",

language = "English (US)",

volume = "116",

pages = "21",

journal = "American Journal of Nursing",

issn = "0002-936X",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Selexipag use is not recommended in patients taking a strong CYP2C8 inhibitor

AU - Aschenbrenner, Diane S.

PY - 2016

Y1 - 2016

UR - http://www.scopus.com/inward/record.url?scp=84962191135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962191135&partnerID=8YFLogxK

U2 - 10.1097/01.NAJ.0000482134.59059.30

DO - 10.1097/01.NAJ.0000482134.59059.30

M3 - Comment/debate

AN - SCOPUS:84962191135

SN - 0002-936X

VL - 116

SP - 21

JO - American Journal of Nursing

JF - American Journal of Nursing

IS - 4

ER -